10,543 Shares in Kenvue Inc. $KVUE Acquired by Almanack Investment Partners LLC.

Almanack Investment Partners LLC. acquired a new position in Kenvue Inc. (NYSE:KVUE) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 10,543 shares of the company’s stock, valued at approximately $221,000.

A number of other hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in Kenvue by 4.9% in the 1st quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company’s stock worth $5,494,882,000 after purchasing an additional 10,600,682 shares during the period. Third Point LLC bought a new stake in Kenvue in the 1st quarter worth approximately $213,422,000. Maverick Capital Ltd. bought a new stake in Kenvue in the 1st quarter worth approximately $203,036,000. Nuveen LLC bought a new stake in Kenvue in the 1st quarter worth approximately $187,123,000. Finally, Voya Investment Management LLC grew its position in Kenvue by 131.3% in the 1st quarter. Voya Investment Management LLC now owns 12,131,468 shares of the company’s stock worth $290,557,000 after purchasing an additional 6,886,784 shares during the period. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on KVUE shares. Citigroup cut their target price on shares of Kenvue from $20.00 to $17.00 and set a “neutral” rating for the company in a research report on Thursday, October 9th. Bank of America cut their target price on shares of Kenvue from $25.00 to $21.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Royal Bank Of Canada cut their price objective on shares of Kenvue from $24.00 to $22.00 and set a “sector perform” rating for the company in a research report on Friday, August 8th. Rothschild & Co Redburn raised shares of Kenvue from a “neutral” rating to a “buy” rating and cut their price objective for the company from $22.50 to $22.00 in a research report on Friday, September 26th. Finally, Canaccord Genuity Group cut their price objective on shares of Kenvue from $29.00 to $26.00 and set a “buy” rating for the company in a research report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $21.18.

Kenvue Trading Down 2.7%

Shares of Kenvue stock opened at $16.21 on Tuesday. The company has a market capitalization of $31.10 billion, a P/E ratio of 21.90, a P/E/G ratio of 2.39 and a beta of 0.72. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98. The company has a fifty day moving average of $19.03 and a 200 day moving average of $21.25. Kenvue Inc. has a fifty-two week low of $15.47 and a fifty-two week high of $25.17.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.01. The company had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. Kenvue’s quarterly revenue was down 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, sell-side analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th were issued a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $0.83 annualized dividend and a yield of 5.1%. This is an increase from Kenvue’s previous quarterly dividend of $0.21. Kenvue’s payout ratio is currently 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.